Reports

Guidelines and Documents

See resources developed by the projects including Guide for IB, IMPD, Clinical study protocol, licensing  and hospital pharmacy functions, including preparation of gene therapy.

ATMP2030 Swedish annual ATMP report 2024.

Kompetensbehov och utbildning inom ATMP.

Gender aspects in the Nordic ATMP Space 2023.

Patient and next-of-kin collaboration for better research and healthcare

Lägesrapport och kartläggning av utbildning och framtida kompetensbehov inom ATMP.

Yearly report of Nordic ATMP status, completed July 2022 by the ATMP2030 National Coordination activity.

Read about the Swelife-ATMP initiatives towards identifying ATMP specific gaps in law, ethics and regulation, as well as identifying specific needs within healthcare, business, research and industry.

Infrastructure report completed March 2021 from the ATMP2030 Innovation Milieu Industrial development activity.

Commercial aspects report completed December 2020 by the Swelife-ATMP health economics project.

Utmaningar och möjligheter för stamcells-baserade läkemedel i Sverige och karta över etiskt och legalt ramverk.

Baselining activity within Swedish ATMP completed October 2020.

Regulatoriska aspekter vid ATMP-utveckling

Swelife-ATMP Gene Therapy report completed February 2020 on opportunities and challenges in Swedish gene therapy.

Pilot Study of a Swedish Institute for Cell Therapy published late 2017.